Home » Immunomedics Completes $37 Million Financing
Immunomedics Completes $37 Million Financing
Immunomedics announced that it closed a private placement of its 5 percent Senior Convertible Notes due 2008 and common stock warrants, which raised a total of $37.675 million. The notes and warrants were sold to qualified institutional buyers and institutional accredited investors. Lazard Freres & Co. LLC, investment banker to the company, served as sole lead placement agent with C.E. Unterberg, Towbin as co-placement agent.
PharmaLive (http://www.pharmalive.com//News/index.cfm?articleid=235024&categoryid=36,61)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May